Core Insights - Senti Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary Gene Circuit platform [1] - The company will present its Gene Circuit technology, pipeline progress, and strategic priorities at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 [1] Company Overview - Senti Bio is dedicated to creating new cell and gene therapies for patients with incurable diseases by leveraging a synthetic biology platform to engineer Gene Circuits [3] - The Gene Circuits are designed to specifically target and kill cancer cells while sparing healthy cells, increasing specificity to target tissues, and allowing for control even after administration [3] - The company's pipeline includes cell therapies engineered with Gene Circuits aimed at addressing challenging liquid and solid tumor indications, with preclinical evidence supporting their efficacy in both NK and T cells [3] - Senti Bio is also exploring the potential applications of Gene Circuits in other modalities and diseases beyond oncology through ongoing partnerships [3]

Core Insights - Senti Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary Gene Circuit platform [1][3] - The company will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 2:00 PM ET [1] - Senti Bio's Gene Circuits are engineered to target cancer cells while sparing healthy cells, enhancing specificity, and allowing for post-administration control [3] Company Overview - Senti Bio is dedicated to creating new medicines for patients with incurable diseases through its synthetic biology platform [3] - The company's pipeline includes cell therapies designed to address challenging liquid and solid tumor indications [3] - Preclinical studies have shown the effectiveness of Senti's Gene Circuits in both NK and T cells, with potential applications beyond oncology [3] Investor Engagement - Management will be available for in-person one-on-one meetings with qualified investors during the conference [2] - A live video webcast of the presentation will be accessible on the company's website, with a replay available for 90 days [2]